Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesAsset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in InventoryChange in ReceivablesDepreciation & Amortization (CF)Depreciation and DepletionExchange Rate EffectFree Cash FlowGains from Investment SecuritiesGains from Sales and DivestituresNet Cash FlowNet IncomeNon-cash ItemsOther financing activitiesShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Glaukos (GKOS) Change in Receivables (2016 - 2025)

Glaukos (GKOS) has disclosed Change in Receivables for 12 consecutive years, with $10.2 million as the latest value for Q4 2025.

  • On a quarterly basis, Change in Receivables rose 89.74% to $10.2 million in Q4 2025 year-over-year; TTM through Dec 2025 was $53.0 million, a 142.38% increase, with the full-year FY2025 number at $53.0 million, up 142.38% from a year prior.
  • Change in Receivables was $10.2 million for Q4 2025 at Glaukos, down from $18.8 million in the prior quarter.
  • In the past five years, Change in Receivables ranged from a high of $18.8 million in Q3 2025 to a low of -$2.2 million in Q3 2021.
  • A 5-year average of $4.0 million and a median of $1.5 million in 2023 define the central range for Change in Receivables.
  • Peak YoY movement for Change in Receivables: plummeted 136.66% in 2021, then surged 3784.17% in 2024.
  • Glaukos' Change in Receivables stood at -$1.2 million in 2021, then surged by 101.41% to $17000.0 in 2022, then soared by 717.65% to $139000.0 in 2023, then soared by 3784.17% to $5.4 million in 2024, then soared by 89.74% to $10.2 million in 2025.
  • Per Business Quant, the three most recent readings for GKOS's Change in Receivables are $10.2 million (Q4 2025), $18.8 million (Q3 2025), and $11.7 million (Q2 2025).